CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dx & Vx Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dx & Vx Co Ltd
1003
Elysia, 173, Digital-ro, Geumcheon-gu
Phone: +82 28908700p:+82 28908700 SEOUL, 08511  South Korea Ticker: 180400180400
Business Summary
Dx & Vx Co Ltd, formerly Cancer Rop Co Ltd, is a Korea-based company primarily engaged in the molecular diagnosis business. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Co-Chief Executive Officer, Director Gyu ChanGwon 53 8/18/2023 8/18/2023
Co-Chief Executive Officer, Director Yong GuLee 56 8/18/2023 5/16/2023
Internal Auditor Han SeongJung 63
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Avixgen 913-914, 254 Cherry Blossom-ro Seoul South Korea

Business Names
Business Name
1804
180400
Avixgen

General Information
Number of Employees: 75 (As of 3/31/2018)
Outstanding Shares: 49,218,583 (As of 9/30/2024)
Shareholders: 12,291
Stock Exchange: KDQ
Fax Number: +82 28908702


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024